Gabrilovich DI - Search Results

1

Syntaphilin Regulates Neutrophil Migration in Cancer.

Fu S, Deng H, Bertolini I, Perego M, Chen ES, Sanseviero E, Mostafa A, Alicea-Torres K, Garcia-Gerique L, Stone EL, Kossenkov AV, Schug ZT, Nam B, Mulligan C, Altieri DC, Nefedova Y, Gabrilovich DI. Fu S, et al. Among authors: gabrilovich di. Cancer Immunol Res. 2023 Mar 1;11(3):278-289. doi: 10.1158/2326-6066.CIR-22-0035. Cancer Immunol Res. 2023. PMID: 36548516 Free PMC article.

2

Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer.

Yu B, Kusmartsev S, Cheng F, Paolini M, Nefedova Y, Sotomayor E, Gabrilovich D. Yu B, et al. Clin Cancer Res. 2003 Jan;9(1):285-94. Clin Cancer Res. 2003. PMID: 12538481

3

Notch signaling is necessary but not sufficient for differentiation of dendritic cells.

Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Cheng P, et al. Blood. 2003 Dec 1;102(12):3980-8. doi: 10.1182/blood-2003-04-1034. Epub 2003 Aug 7. Blood. 2003. PMID: 12907456 Free article.

4

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D. Kusmartsev S, et al. Cancer Res. 2003 Aug 1;63(15):4441-9. Cancer Res. 2003. PMID: 12907617

5

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.

Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Nefedova Y, et al. Among authors: gabrilovich di. Blood. 2004 May 1;103(9):3503-10. doi: 10.1182/blood-2003-07-2340. Epub 2003 Dec 11. Blood. 2004. PMID: 14670925 Free article.

6

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D. Nefedova Y, et al. J Immunol. 2004 Jan 1;172(1):464-74. doi: 10.4049/jimmunol.172.1.464. J Immunol. 2004. PMID: 14688356

7

Full-length dominant-negative survivin for cancer immunotherapy.

Pisarev V, Yu B, Salup R, Sherman S, Altieri DC, Gabrilovich DI. Pisarev V, et al. Among authors: gabrilovich di. Clin Cancer Res. 2003 Dec 15;9(17):6523-33. Clin Cancer Res. 2003. PMID: 14695157

8

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Kusmartsev S, et al. Among authors: gabrilovich di. J Immunol. 2004 Jan 15;172(2):989-99. doi: 10.4049/jimmunol.172.2.989. J Immunol. 2004. PMID: 14707072

9

Rational design of shepherdin, a novel anticancer agent.

Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG, Meli M, Dohi T, Fortugno P, Nefedova Y, Gabrilovich DI, Colombo G, Altieri DC. Plescia J, et al. Among authors: gabrilovich di. Cancer Cell. 2005 May;7(5):457-68. doi: 10.1016/j.ccr.2005.03.035. Cancer Cell. 2005. PMID: 15894266 Free article.

10

Activation of dendritic cells via inhibition of Jak2/STAT3 signaling.

Nefedova Y, Cheng P, Gilkes D, Blaskovich M, Beg AA, Sebti SM, Gabrilovich DI. Nefedova Y, et al. Among authors: gabrilovich di. J Immunol. 2005 Oct 1;175(7):4338-46. doi: 10.4049/jimmunol.175.7.4338. J Immunol. 2005. PMID: 16177074 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters